Search Results - "Janus Kinase Inhibitors pharmacology"

Dermatologie. Nouvelles utilisations des inhibiteurs de JAK en dermatologie : panacée mais à quel prix ?

Authors: Russo, Giuseppe Laffitte, Emmanuel Alexis Cortes Sanchez, Begonia

Source: Revue Médicale Suisse. 20:241-246

Subject Terms: Alopecia Areata / drug therapy, Janus Kinase Inhibitors / pharmacology, Humans, Cytokines, Dermatology, Janus Kinase Inhibitors / therapeutic use, Dermatitis, Atopic

File Description: application/pdf

Access URL: https://archive-ouverte.unige.ch/unige:183423
https://doi.org/10.53738/revmed.2024.20.859.241

An evaluation of baricitinib as a therapeutic option for adult patients with moderate to severe atopic dermatitis

Authors: Mendes, Jocelyn T. Balogh, Esther A. Strowd, Lindsay C. et al.

Source: Mendes, J T, Balogh, E A, Strowd, L C & Feldman, S R 2020, ' An evaluation of baricitinib as a therapeutic option for adult patients with moderate to severe atopic dermatitis ', Expert Opinion on Pharmacotherapy, vol. 21, no. 9, pp. 1027-1033 . https://doi.org/10.1080/14656566.2020.1739268

Subject Terms: Adult, Sulfonamides, Atopic dermatitis, baricitinib, eczema, systemic agent, Sulfonamides/pharmacology, Azetidines/pharmacology, small molecule inhibitor, Dermatitis, Dermatitis, Atopic, 3. Good health, Atopic/drug therapy, 03 medical and health sciences, 0302 clinical medicine, JAK inhibitor, Double-Blind Method, Janus Kinase Inhibitors/pharmacology, Purines, Dermatitis, Atopic/drug therapy, Humans, Azetidines, Janus Kinase Inhibitors, Pyrazoles, Randomized Controlled Trials as Topic

Access URL: https://pubmed.ncbi.nlm.nih.gov/32208940
https://portal.findresearcher.sdu.dk/da/publications/an-evaluation-of-baricitinib-as-a-therapeutic-option-for-adult-pa
https://www.tandfonline.com/doi/full/10.1080/14656566.2020.1739268
https://www.ncbi.nlm.nih.gov/pubmed/32208940
https://europepmc.org/article/MED/32208940
https://portal.findresearcher.sdu.dk/da/publications/aeea7a82-7686-430a-b268-94f954ea916a
https://doi.org/10.1080/14656566.2020.1739268
https://portal.findresearcher.sdu.dk/da/publications/aeea7a82-7686-430a-b268-94f954ea916a

Allosteric TYK2 inhibition:redefining autoimmune disease therapy beyond JAK1-3 inhibitors

Authors: Jensen, Lise Torp Attfield, Kathrine E. Feldmann, Marc et al.

Source: Jensen, L T, Attfield, K E, Feldmann, M & Fugger, L 2023, 'Allosteric TYK2 inhibition : redefining autoimmune disease therapy beyond JAK1-3 inhibitors', EBioMedicine, vol. 97, 104840. https://doi.org/10.1016/j.ebiom.2023.104840

Subject Terms: Autoimmune disease, Deucravacitinib, JAK inhibitors, TYK2, Cytokines, Humans, Janus Kinase Inhibitors/pharmacology, Psoriasis/drug therapy, Janus Kinase 1/genetics, TYK2 Kinase/genetics, Autoimmune Diseases/drug therapy

Availability: https://pure.au.dk/portal/en/publications/d6f06a24-db6e-4c1a-ac43-54857d4f014f
https://doi.org/10.1016/j.ebiom.2023.104840
http://www.scopus.com/inward/record.url?scp=85174142301&partnerID=8YFLogxK